Category Archives: 2022 Events

Penang, 30 November 2022 –  Thirty AMMI members attended the AMMI Q4 Progress Meeting and Updates at Ascott Gurney Hotel.  AMMI Chairman, Mr Andy Lee welcomed all to the meeting. First up was the introduction by new member, Dexcom. This was followed by updates from AMMI committees – Government Affairs, Regulatory Affairs, Talent Development, Operational Excellence and Membership & Industry Development. Before the session ended, AMMI Executive Director, Mr CS Ching updated members on upcoming events and training. After the meeting, members adjourned upstairs for the AMMI Networking Cocktail Session and Gala Dinner.

Penang, 1 Dec 2022 – The Association of Malaysian Medical Industries (AMMI) organised its inaugural Malaysia MedTech Industry Summit  in conjunction with Penang’s 50^th Anniversary of Industrialization, supported by Penang State  Government, InvestPenang, Penang Development Corporation (PDC) and Malaysian Investment Development Authority (MIDA).

The objective of the event was to serve as a platform for local suppliers to connect with medical device manufacturers. The summit saw many presentations and best-practice sharing sessions.

Mr Andy Lee gave the Welcome Remarks, followed by the Keynote Speech by Penang Chief Minister, YAB Tuan Chow Kon Yeow.  The first half of the summit saw presentations by Ms Lim Bee Vian (Deputy CEO, Investment Development MIDA) and Dato’ Seri Lee Kah Choon (Special Investment Advisor to CM) on Creating a Robust MedTech Ecosystem. 

Here is a recap of the other topics in the morning session.

Improving Manufacturing Excellence Industry-Wide

Speakers:
1. Sayron Ruiz, Director, Manufacturing Engineering, Boston Scientific Penang
2. Michel Van Crombrugge, AMMI Treasurer/ Leader of  AMMI OpEx Committee; Country Manager, Paramit.TECAN
3. Dato’ Hans Brenner, AMMI OpEx, Committee Member; Director, KLS Martin Group
4. Ms Hawwa Nouay, Director, Operational Excellence, B. Braun Medical Industries

Sustainability in MedTech Manufacturing and Outlook

Speakers:

• JC Guillou,  AMMI Board Member;  VP, Global Operations & Sourcing, Gloves, Molnlycke Health Care
• Elmar Friesnegger,  AMMI OpEx Committee Member; VP Central Functions Plant Operations, B. Braun Medical Industries
• Gogielan Nantha Kumar, Deputy Director, Green Technology Division, Malaysian Investment Development Authority (MIDA)

Panel Discussion: Building the Talent Pipeline and Creative Retention Strategies in the Medical Device Industry

The panel discussion was moderated by Ms Tan Lin Im,  AMMI Talent Development Committee Co-Leader; APAC Regional Senior HR Director, Teleflex Medical. Panel members were:

• Jason Ng, AMMI Government Affairs/RA/ OpEx Committee Member; Manufacturing VP, UWHM (UMediC Group)
• George Kazzi, General Manager – Malaysia & Philippine, Head of Commercial Excellence India/SEA, Baxter International Inc
• Ir Dr. Nasrul Anuar Abd. Razak, Head of Biomedical Department, University of Malaya
• Joyce Ong, HR Director, Boston Scientific Penang

Supply Chain Session: Achieving Supply Chain Resilience: Strengthening Medical Device Ecosystem

Dato’ Loo Lee Lian, CEO of Invest Penang gave the Opening Remarks for the afternoon session.  The session was created for the medical device companies to share their latest sourcing requirements and parts that they would like to localize in Malaysia.  Boston Scientific, Cochlear, Dexcom, Smith & Nephew, Tako Astatic Technology and Japan Lifeline (JLL Malaysia) shared about their companies, products and supply chain needs.  The evening ended with Networking Cocktail Session for the attendees.

From left: Ms Azlina Hamdan, Director of MIDA Life Sciences & Medical Technology Division; Ms Umarani Muniandy, MIDA Executive Director (Manufacturing Development -Resource); Yang Berbahagia Datuk Wira Arham Abdul Rahman, MIDA CEO; Mr Andy Lee Kuan Min, AMMI Chairman; Yang Berbahagia Dato’ Seri Dr Haji Haminnuddin, AMMI Secretary-General; Mr Michel Van Crombrugge, AMMI Treasurer.

14 November 2022, Penang – The Malaysian Investment Development Authority (MIDA) and the Association of Malaysian Medical Industries (AMMI) today released the AMMI Medical Device Industry Status and Outlook 2021/2022. The report highlighted that the Malaysian medical device industry demonstrated remarkable resilience despite COVID-19 pandemic challenges.  AMMI Chairman, Mr Andy Lee presented the report to MIDA CEO, Y.Bhg Datuk Wira Arham Abdul Rahman during the joint MIDA-AMMI press conference.

From left: Mr George Kazzi, General Manager, Baxter Malaysia; Y.Bhg. Dato’ Zamzuri bin Abdul Aziz, Deputy Secretary General (Finance), MOH; Ms Aida Basri, Government Affairs & Market Access Lead, Medtronic Malaysia; Mr CS Ching, Executive Director, AMMI; Y.Bhg. Dato’ Seri Dr Haji Haminnuddin bin Haji Abd. Hamid, Secretary General, AMMI; Mr Andy Lee, Chairman, AMMI; YB Khairy Jamaluddin, Minister of Health; Y.Bhg. Tan Sri Dato’ Seri Dr Noor Hisham bin Abdullah, Director General of Health; Dr Mohd Emil Azril Bahari Md Noor, General Manager, Government Affairs & Market Access, B. Braun; Mr Samuel Pooranakaran, Vice Chairman, AMMI.

• Include renewal/re-registration clause, which specifies auto-renewal for medical device registration (product registration);
• Confine the post-market surveillance & vigilance requirement to local cases only;
• Exclude the export of medical devices from the scope of the Medical Device Act.